http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4013766-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fee9d9493ec24563664e7dba28ad18de |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-048 |
| filingDate | 2020-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9096589cd4675bf816ea91fe25a25d4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c40db1f4f162140d1850a21ca43f1cd4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6162f1e4093226ad6d8dfbe5837ccfbc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc4a9cec5c56ac3fe709cf4e92199cd7 |
| publicationDate | 2022-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-4013766-A1 |
| titleOfInvention | Compounds and compositions for differential modulation of nicotinamide adenine dinucleotide |
| abstract | The invention relates to compounds and compositions for differential modulation of nicotinamide adenine dinucleotide (NAD) in various tissues or cell types. Further, the invention relates to pharmaceutical compositions containing one or more NAD-modulating compounds as an active pharmaceutical ingredient. The invention also relates to methods of making such compounds and compositions. Methods of using such compounds or compositions include administration of such compounds and compositions to promote the increase or maintenance of intracellular levels of nicotinamide adenine dinucleotide (NAD) in healthy cells and tissues thus improving healthy cell and tissue survival. Also included are methods of increasing or maintaining intracellular levels of NAD in selected cells or tissues while simultaneously reducing NAD levels in unhealthy tissue or cells thus reducing the survival of unhealthy cells and tissue. |
| priorityDate | 2019-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 425.